Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Escherichia coli (E. coli) are common Gram-negative bacteria causing various infections.
• Lactoferrin (LF) is a milk protein with antimicrobial, anti-cancer, antioxidant, and immunomodulatory properties.
• Lactoferricin (LFcin), derived from LF, exhibits enhanced antimicrobial activity.

Purpose of the Study:

• To evaluate the antimicrobial efficacy of lactoferrin (LF) and lactoferricin (LFcin) against E. coli and other pathogens.
• To assess the protective effects of LF in the digestive tract of a transgenic animal model.
• To investigate the immunomodulatory effects of LF as a feed additive in avian species.

Main Methods:

• In vitro studies demonstrating antimicrobial activity of recombinant porcine LF (pLF) and synthetic LFcin.
• Pathogen challenge studies in a transgenic milk-fed animal model to assess LF's in vivo activity in the digestive tract.
• Evaluation of pLF as a feedstuff additive on avian immune responses, including antibody formation and cell-mediated immunity.

Main Results:

• LF and LFcin demonstrated in vitro antimicrobial activity against pathogenic bacteria, including antibiotic-resistant strains.
• LF exhibited broad-spectrum antimicrobial activity within the digestive tract and protected the small intestine mucosa from injury in vivo.
• pLF supplementation enhanced avian immunity, boosting antibody production and cell-mediated responses.

Conclusions:

• LF possesses broad-spectrum antimicrobial properties effective against E. coli and other pathogens in both in vitro and in vivo settings.
• LF demonstrates protective effects on the digestive tract mucosa and enhances host immunity.
• LF and LFcin represent promising natural protein-based strategies for preventing and treating infections caused by E. coli and antibiotic-resistant bacteria.